Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease
- Status
- COMPLETED
- Phase
- PHASE3
S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia
- Status
- COMPLETED
- Phase
- PHASE2
Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE4